使用抗体药物合物的单疗法和组合疗法,用于治疗抗性卵巢癌
Ke Shen1, Shuang Yuan1, Ning Su1
1Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Oncology reports
|April 17, 2025
概括
抗体与药物联合体 (ADCs) 为抗性卵巢癌 (PROC) 提供了一个有前途的新疗法. 与化疗相比,Mirvetuximab soravtansine显示出更高的疗效,突出了卵巢癌治疗中的ADC潜力.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 抗性卵巢癌 (PROC) 是一个重大的临床挑战,有效的治疗选择有限.
- 常规的细胞毒性化疗对于PROC往往导致不满意的疗效,高毒性和不良副作用.
- 抗体-药物联合体 (ADC) 是一种新的治疗策略,它将向的抗体输送与强大的细胞毒性有效载荷相结合.
研究的目的:
- 审查当前关于应用抗体-药物联合体 (ADC) 在抗性卵巢癌 (PROC) 的研究进展.
- 探索ADCs作为PROC的单一治疗和组合治疗的潜力.
- 讨论在PROC治疗中ADC开发的未来方向.
主要方法:
- 在PROC中对ADC进行现有文献和临床试验数据的审查.
- 已批准和正在研究的ADC的疗效和安全性分析.
- 评估特定抗原,如叶酸受体α (FRα) 在ADC向中的作用.
主要成果:
- 对FRα阳性PROC的Mirvetuximab soravtansine的批准标志着ADC治疗的重大进展.
- 在FRα阳性PROC中,III期试验显示了Mirvetuximab soravtansine (42.3%) 与化疗 (15.9%) 相比的客观缓解率更高.
- 在PROC治疗中,ADC显示出提高治疗疗效和降低全身毒性的潜力.
结论:
- ADCs是对抗性卵巢癌的一种有前途的治疗方式,提供有针对性的分娩和改善的结果.
- 米尔韦图西马布索拉夫坦辛 (Mirvetuximab soravtansine) 是PROC中ADCs临床成功和潜力的例子.
- 对ADC单疗法和组合策略的进一步研究对于推进PROC治疗至关重要.
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
400
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
400
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
Combined Effects of Drugs: Synergism
3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.6K


